3 UNDERVALUED TSX Stocks to Buy Right Now – The Motley Fool Canada
Looking for value plays in such a frothy market? Here are three undervalued TSX stocks that could continue to soar higher.
August 13, 2021
10 Best Stocks to Invest In According to Philip Timon’s Owls Nest Partners
In this article, we will discuss the 10 best stocks to invest in according to Philip Timon’s Owls Nest Partners based on Q1 holdings…
Intel added new stake in Coinbase stock, valued at more than $750,000
Intel Corp. disclosed Friday that it invested in Coinbase Global Inc.’s stock during the second quarter, soon after the cryptocurrency…
Review: The Furo X is a great folding electric bike, but not a perfect one
While most bike manufacturers like to claim their electric bikes are suitable for almost anything, it’s clear that the Furo X…
Race to build affordable heat pumps for Britain’s homes hots up, but will the public warm to them? – Telegraph.co.uk
Government wants homeowners to switch to clean, green heating, but ministers are said to be getting cold feet over a ban on new…
Watch Rimac Nevera Break World’s Quickest Production Car Record – Motor1
Brooks from DragTimes drove the Rimac Nevera at Famoso Raceway in California and set a new world record with an elapsed time…
Market Extra: Consumers’ dashed hopes for an end to the pandemic are at risk of spilling over into higher inflation expectations for the next 12 months
The longer the economy and society remain “distorted or abnormal” relative to the pre-Covid era, “the longer and higher the inflation…
Post-Short Squeeze, Is Appian Stock a Buy Following Q2 Earnings?
Yet another quarter of solid results are the real highlight here for this cloud computing and enterprise software company.
Hall of Fame Resort & Entertainment’s (HOFV) CEO Michael Crawford on Q2 2021 Results – Earnings Call Transcript
Hall of Fame Resort & Entertainment Company (NASDAQ:HOFV) Q2 2021 Earnings Conference Call August 13, 2021 8:30 AM ETCompany…
Sesen Bio Receives Complete Response Letter from FDA for Vicineum™ (oportuzumab monatox-qqrs) – Business Wire
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of…